Search - tctmd.com

Displaying 501 - 520 of 838

Sort: Relevancy | Date

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Todd Neale

February 10, 2020

News Daily News

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Caitlin E. Cox

February 07, 2020

News Daily News

Kidney Transplant Boosts CV Functional Reserve

Todd Neale

February 07, 2020

News Daily News

Meat Consumption Linked to Small Rises in CVD, All-Cause Mortality Risks

Michael O'Riordan

February 05, 2020

News Daily News

‘Super-Dense’ Calcified Plaque Appears Protective Against ACS

Michael O'Riordan

January 24, 2020

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

News Daily News

Pot Talk: Review Urges Cardiologists to Discuss Marijuana Use

L.A. McKeown

January 21, 2020

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

News Daily News

Hypertension Starts Years Earlier in Women Than Men, Serial BP Shows

L.A. McKeown

January 17, 2020

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Daily News

Aspirin Not Protective Against CVD in Black Patients

Caitlin E. Cox

December 18, 2019

News Daily News

Higher Chili Pepper Consumption Linked to Fewer CVD Deaths

L.A. McKeown

December 17, 2019

News Daily News

FDA Approves Icosapent Ethyl for Reducing CVD Events

Michael O'Riordan

December 13, 2019

News Daily News

‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD

Yael L. Maxwell

December 12, 2019

News Daily News

Poor Exercise Capacity on Stress Echo in Women Predicts Death From CVD

Michael O'Riordan

December 10, 2019

News Daily News

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

Michael O'Riordan

December 03, 2019

News Daily News

Grief and CVD: Simple Regimen May Lower Risk

L.A. McKeown

November 19, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News

Testosterone Therapy Ups VTE Risk, Even When Indicated

Caitlin E. Cox

November 12, 2019

Advertisement

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Kidney Transplant Boosts CV Functional Reserve

Meat Consumption Linked to Small Rises in CVD, All-Cause Mortality Risks

‘Super-Dense’ Calcified Plaque Appears Protective Against ACS

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Pot Talk: Review Urges Cardiologists to Discuss Marijuana Use

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Hypertension Starts Years Earlier in Women Than Men, Serial BP Shows

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Aspirin Not Protective Against CVD in Black Patients

Higher Chili Pepper Consumption Linked to Fewer CVD Deaths

FDA Approves Icosapent Ethyl for Reducing CVD Events

‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD

Poor Exercise Capacity on Stress Echo in Women Predicts Death From CVD

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

Grief and CVD: Simple Regimen May Lower Risk

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Testosterone Therapy Ups VTE Risk, Even When Indicated

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content